mdlinx mdlinx
Latest (57) Full Text Focus on MI Article Summary

Body Composition and Coronary Heart Disease Mortality—An Obesity or a Lean Paradox Full Text
Mayo Clinic Proceedings, 08/31/2011  Exclusive author commentary  Clinical Article

Lavie CJ et al. - Although both low BF and low body mass index (BMI) are independent predictors of mortality in patients with coronary heart disease (CHD), only patients with combined low body fat (BF)/low BMI appear to be at particularly high risk of mortality during follow-up. Studies are needed to determine optimal body composition in the secondary prevention of CHD.

Methods
  • The authors studied 581 patients with CHD between January 1, 2000, and July 31, 2005, who were divided into low (<25) and high BMI (≥25), as well as low (≤25% men and ≤35% women) and high BF (>25% in men and >35% in women).
  • Four groups were analyzed by total mortality during the 3-year follow-up by National Death Index: low BF/low BMI (n=119), high BF/low BMI (n=26), low BF/high BMI (n=125), and high BF/high BMI (n=311).

Results
  • During the 3-year follow-up, mortality was highest in the low BF/low BMI group (11%), which was significantly (P<.001) higher than that in the other 3 groups (3.9%, 3.2%, and 2.6%, respectively); using the high BF/high BMI group as a reference, the low BF/low BMI group had a 4.24-fold increase in mortality (confidence interval [CI], 1.76-10.23; P=.001).
  • In multivariate logistic regression for mortality, when entered individually, both high BMI (odds ratio [OR], 0.79; CI, 0.69-0.90) and high BF (OR, 0.89; CI, 0.82-0.95) as continuous variables were independent predictors of better survival, whereas low BMI (OR, 3.60; CI, 1.37-9.47) and low BF (OR, 3.52; CI, 1.34-9.23) as categorical variables were independent predictors of higher mortality.

Carl J. Lavie (09/02/2011) comments:
Many studies have assessed the Obesity Paradox just with BMI. Our study is unique in that we also studied body composition with both BMI as well as % Body Fat(BF). In a large cohort with stable CHD, only those with both low BMI and low BF had a high 3-year mortality of 11%, whereas all of the other patients had a mortality of only 3 %. Both Low BMI and Low BF were independent predictors of higher mortality, increasing mortality by approximately 3.5-fold. I have an author interview , which can be viewed by going to the Mayo Clinic Proceedings web-site and looking at the Current Issue(or September, 2011 issue.)

Read this article in Mayo Clinic Proceedings read MDLinx article: Body Composition and Coronary Heart Disease Mortality—An Obesity or a Lean Paradox

<< Previous Article | Next Article >>
Showing Latest Articles
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Cardiology Articles

Last month's top read Top 50 of 2011

1 Comparison of alternate day atorvastatin treatment to daily treatment in maintaining LDL-Cholesterol targets in patients with variable coronary risk profile Journal of Cardiovascular Pharmacology, April 2, 2012    Clinical Article

2 Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials Full Text Lipids in Health and Disease, April 5, 2012    Free full text

3 Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the lunar study) The American Journal of Cardiology, April 17, 2012    Clinical Article

4 Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation British Journal of Clinical Pharmacology, April 24, 2012    Clinical Article

5 Evidence-based Use of Statins for Primary Prevention of Cardiovascular Disease American Journal of Medicine, April 9, 2012    Evidence Based Medicine    Clinical Article

6 Statins as a possible cause of inflammatory and necrotizing myopathies Atherosclerosis, April 23, 2012    Clinical Article

7 Association of Treatment With Losartan vs Candesartan and Mortality Among Patients With Heart Failure JAMA, April 12, 2012    Clinical Article

8 Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias Pharmacoepidemiology and Drug Safety, April 4, 2012    Clinical Article

9 Effects of Celecoxib On Restenosis after Coronary Intervention and Evolution of Atherosclerosis (Mini-COREA) Trial: celecoxib, a double-edged sword for patients with angina European Heart Journal, March 12, 2012    Clinical Article

10 Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial Catheterization and Cardiovascular Interventions, April 19, 2012    Clinical Article

11 Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease Heart and Vessels, March 22, 2012    Clinical Article

12 Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study European Heart Journal, April 25, 2012    Clinical Article

13 On-treatment non–high-density lipoprotein cholesterol, apolipoprotein b, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy JACC - Journal of the American College of Cardiology, April 18, 2012    Clinical Article

14 STAR VaS - Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery Canadian Journal of Anesthesia, April 16, 2012    Clinical Article

15 Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) European Heart Journal, April 27, 2012    Clinical Article

16 Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the truth study) The American Journal of Cardiology, April 26, 2012    Clinical Article

17 Statin therapy is associated with aneurysm sac regression after endovascular aortic repair Journal of Vascular Surgery, April 3, 2012    Clinical Article

18 Vitamin D deficiency, CD4+CD28null cells and Accelerated Atherosclerosis in Chronic Kidney Disease Nephrology, April 13, 2012    Clinical Article

19 Effect of omega-3 fatty acids supplementation on endothelial function: A meta-analysis of randomized controlled trials Atherosclerosis, April 4, 2012

20 Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: The potential role for regulatory T cells Atherosclerosis, April 20, 2012    Clinical Article

Indexed Journals in Cardiology: American Heart Journal, American Journal of Cardiology, Circulationn, Heartmore

Other Topics in Cardiology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close